血小板活化标志物、维生素D与氯吡格雷抵抗的相关性

doi:10.3969/j.issn.1006-9771.2019.05.013

《中国康复理论与实践》 ›› 2019, Vol. 25 ›› Issue (5): 570-574.doi: 10.3969/j.issn.1006-9771.2019.05.013

血小板活化标志物、维生素D与氯吡格雷抵抗的相关性

陈亮¹, 刘媛¹, 梁林¹, 董娜¹, 刘志忠^1,2

1.中国康复研究中心北京博爱医院检验科，北京市 100068
2.首都医科大学附属北京天坛医院实验诊断中心，北京市 100070

收稿日期:2018-09-02 修回日期:2018-10-29 出版日期:2019-05-25 发布日期:2019-05-29
通讯作者: 刘志忠，主任检验师、副教授，主要研究方向：血小板活化标志物的实验室检测与临床应用。E-mail: lzzlab@126.com
作者简介:陈亮(1977-)，男，汉族，吉林松原市人，在职硕士研究生，主管检验技师，主要研究方向：血小板活化标志物的实验室检测与临床应用。
基金资助:
北京市科学技术委员会首都临床特色应用研究(吴阶平)专项(No. Z151100004615002)

Relationship of Platelet Activation Markers and Vitamin D to Clopidogrel Resistance

CHEN Liang¹, LIU Yuan¹, LIANG Lin¹, DONG Na¹, LIU Zhi-zhong^1,2

1.Department of Laboratory, Beijing Bo'ai Hospital, China Rehabilitation Research Center, Beijing 100068, China
2.Center for Laboratory Diagnosis, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China

Received:2018-09-02 Revised:2018-10-29 Published:2019-05-25 Online:2019-05-29
Contact: LIU Zhi-zhong, E-mail: lzzlab@126.com
Supported by:
Beijing Science and Technology Commission Capital Clinical Application Research Program (No. Z151100004615002)

摘要/Abstract

摘要： 目的探讨血小板活化标志物、维生素D与缺血性脑卒中患者抗血小板药物抵抗的相关性。方法 2017年6月至2018年6月，190例接受阿司匹林和氯吡格雷联合治疗的缺血性脑卒中患者，于用药后7~10 d检测二磷酸腺苷(ADP)和花生四烯酸(AA)诱导的最大血小板聚集率(MPAR)、血小板CD_62p活化百分率、血浆P选择素和维生素D。根据MPAR将患者分为抗血小板药物抵抗组和敏感组。结果阿司匹林抵抗率为1.2%，氯吡格雷抵抗率24.7% (抵抗组47例，敏感组143例)。抵抗组血小板CD_62p活化百分率(t = -5.232, P < 0.001)、高血压患病率(χ² = 4.878, P < 0.05)均高于敏感组，维生素D浓度明显低于敏感组(t = 3.052, P < 0.01)，两组血浆P选择素浓度无显著性差异(t = -0.684, P = 0.253)。Logistic回归分析结果显示，高血压(OR = 5.538, 95% CI: 1.204~25.470, P < 0.05)、血小板CD_62P活化百分率(OR = 1.082, 95% CI: 1.041~1.092, P < 0.05)是氯吡格雷抵抗的危险因素，而维生素D (OR = 0.848, 95% CI: 0.755~0.953, P < 0.01)是氯吡格雷抵抗的保护因素。结论抑制血小板活化和补充维生素D可能有助于提高氯吡格雷的疗效。

关键词: 缺血性脑卒中, 血小板活化, 维生素D, 抗血小板治疗, 药物抵抗

Abstract: Objective To explore the relationship of platelet activation markers and vitamin D to antiplatelet drug resistance in ischemic stroke patients.Methods From June, 2017 to June, 2018, 190 patients with ischemic stroke were tested their maximum platelet aggregation rate (MPAR) induced by adenosine diphosphate (ADP) and arachidonic acid (AA), activation of platelet CD_62P and P-selectin vitamin D seven to ten days after dual antiplatelet treatment (aspirin 100 mg/d + clopidogrel 75 mg/d). According to the MPAR induced by ADP and AA, the patients were divided into resistance group and sensitive group. Results The prevalence of aspirin resistance was 1.2%, while the prevalence of clopidogrel resistance was 24.7% (47 in the resistance group and 143 in the sensitive group). The activation of platelet CD_62P (t = -5.232, P < 0.001) and the prevalence of hypertension (χ² = 4.878, P < 0.05) were more in the resistance group than in the sensitive group, while the vitamin D concentration was less (t = 3.052, P < 0.01). There was no significant difference in P-selectin between the resistance and sensitive groups (t = -0.684, P = 0.253). Logistic regression analyses showed that hypertension (OR = 5.538, 95% CI: 1.204-25.470, P < 0.05), activation of platelet CD_62P (OR = 1.082, 95% CI: 1.041-1.092, P < 0.05) and vitamin D (OR = 0.848, 95% CI: 0.755-0.953, P < 0.01) were the independent related factors for clopidogrel resistance. Conclusion Inhibition of platelet activation and supplementation of vitamin D may help to overcome the resistance of clopidogrel.

Key words: ischemic stroke, platelet activation, vitamin D, antiplatelet therapy, drug resistance

中图分类号:

R743.3

陈亮, 刘媛, 梁林, 董娜, 刘志忠. 血小板活化标志物、维生素D与氯吡格雷抵抗的相关性[J]. 《中国康复理论与实践》, 2019, 25(5): 570-574.

CHEN Liang, LIU Yuan, LIANG Lin, DONG Na, LIU Zhi-zhong. Relationship of Platelet Activation Markers and Vitamin D to Clopidogrel Resistance[J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2019, 25(5): 570-574.

参考文献

1 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014 [J]. 中华神经科杂志, 2015, 48(4): 258-273.
2 KimJ T, HeoS H, ChoiK H, et al. Clinical implications of changes in individual platelet reactivity to aspirin over time in acuteischemic stroke [J]. Stroke, 2015, 46(9): 2534-2540.
3 KimJ T, ChoiK H, ParkM S, et al. Clinical significance of acute and serial platelet function testing in acute ischemic stroke [J]. J Am Heart Assoc, 2018, 7(11): e008313.
4 YiX, LinJ, ZhouQ, et al. Clopidogrel resistance increases rate of recurrent stroke and other vascular events in Chinese population [J]. J Stroke Cerebrovasc Dis, 2016, 25(5): 1222-1228.
5 陈涓涓,陈淮菁,林凯华,等. P选择素、P选择素糖蛋白配体-1及C反应蛋白与青年性脑梗死不同TOAST亚型的关系[J]. 广东医学, 2014, 35(24): 3831-3833.
6 王景尚,孙明月,殷惠军,等. 阿司匹林对波动高糖诱导内皮损伤过程中血小板活化的影响[J]. 中国药理学通报, 2018, 34(1): 50-54.
7 BesterJ, PretoriusE. Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity [J]. Sci Rep, 2016, 6: 32188.
8 SilvagnoF, de VivoE, AttanasioA, et al. Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes [J]. PLoS One. 2010, 5(1): e8670.
9 BorstO, MuenzerP, SchmidE, et al. 1,25(OH)2 vitamin D3 dependent inhibition of platelet Ca2+ signaling and thrombus formation on klotho-deficient mice [J]. FASEB J, 2014, 28: 2108-2119.
10 王志军,王硕,王泽宇,等. 介入治疗对冠心病患者血小板活化指标和抗血小板治疗效果及预后的影响研究[J]. 中国全科医学, 2017, 20(33): 4125-4129.
11 王婷婷,陈玮琪,王伊龙. 缺血性脑卒中的精准抗血小板治疗[J]. 精准医学杂志, 2018, 33(1): 86-91.
12 WuX, LiuG, LuJ, et al. Administration of ticagrelor and double-dose clopidogrel based on platelet reactivity determined by verify now-P2Y12 for Chinese subjects after elective PCI [J]. Int Heart J, 2017, 58(2): 167-173.
13 GonzálezA, MonicheF, CayuelaA, et al. Effect of CYP2C19 polymorphisms on the platelet response to clopidogrel and influence on the effect of high versus standard dose clopidogrel in carotid artery stenting [J]. Eur J Vasc Endovasc Surg, 2016, 51(2): 175-186.
14 马丽,李杰,穆叶塞,等. 急诊介入治疗前后AMI患者P选择素和血小板膜糖蛋白GPⅡb/Ⅲa复合物表达研究[J]. 新疆医科大学学报, 2015, 38(9): 1110-1112.
15 胡晓芳,李娜,王玉红,等. 血小板膜糖蛋白与缺血性脑血管病关系的研究[J]. 中国实验诊断学, 2014, 18(12): 1988-1990.
16 黄涛,王海侨. PAC-1、CD62p和D-Dimer含量与急性脑梗死患者梗死体积的相关性[J]. 中国老年学杂志, 2013, 33(14): 3302-3303.
17 蔡玮婷,彭瑜,张钲. 血小板及其趋化因子在动脉粥样硬化中作用的研究进展[J]. 中国循环杂志, 2016, 31(8): 816-818.
18 PikeJ W, ChristakosS. Biology and mechanisms of action of the vitamin D hormone [J]. Endocrinol Metab Clin N Am, 2017, 46(4): 815-843.
19 ChenY, KongJ, SunT, et al. 1,25-Dihydroxyvitamin D(3) suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-kappaB activation [J]. Arch Biochem Biophys, 2011, 507(2): 241-247.
20 SultanM, TwitoO, TohamiT, et al. Vitamin D diminishes the high platelet aggregation of type 2 diabetes mellitus patients [J]. Platelets, 2019, 30(1): 120-125.
21 Korzonek-SzlachetaI, HudzikB, NowakJ, et al. Mean platelet volume is associated with serum 25-hydroxyvitamin D concentrations in patientswith stable coronary artery disease [J]. Heart Vessels, 2018, 33(11): 1275-1281.
22 NorisP, MelazziniF, BalduiniC L. New roles for mean platelet volume measurement in the clinical practice? [J]. Platelets, 2016, 27(7): 607-612.
23 YildizB S, OzkanE, EsinF, et al. Does high serum uric acid level cause aspirin resistance? [J]. Blood Coagul Fibrinolysis, 2016, 27(4): 412-418.
24 BarbieriL, VerdoiaM, PergoliniP, et al. Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor [J]. Nutr Metab Cardiovasc Dis, 2016, 26(4): 352-358.
25 董海荣,徐肖倩,康德成,等. CP2C19基因多态性与中国北方地区人群缺血性脑卒中氯吡格雷抵抗的相关性研究[J]. 国际检验医学杂志, 2018, 39(7): 820-823.
26 SuJ F, HuX H, LiC Y. Risk factors for clopidogrel resistance in patients with ischemic cerebral infarction and the correlation with ABCB1 gene rs1045642 polymorphism [J]. Exp Ther Med, 2015, 9(1): 267-271.

[1]	邓婷, 陈敬绵, 刘小蒙, 姚晓华, 刘芦姗, 何威, 张通, 芦海涛. 轻中度急性缺血性脑卒中并发卒中相关性肺炎的危险因素分析[J]. 《中国康复理论与实践》, 2023, 29(6): 708-713.
[2]	刘慧珍, 商娜, 李俊玉, 王娜, 李芳, 刘小蒙, 郭树彬. 血清25-羟维生素D与急诊病房卒中相关性肺炎发生及预后的相关性[J]. 《中国康复理论与实践》, 2023, 29(10): 1214-1220.
[3]	张春龙, 刘福亮, 商娜, 李芳, 刘慧珍. 血清脂联素、超敏C-反应蛋白与急性缺血性脑卒中短期预后的相关性[J]. 《中国康复理论与实践》, 2023, 29(10): 1221-1226.
[4]	赖海芳,顾琳,纵亚,牛传欣,谢青. 采用多层感知器神经网络构建亚急性期缺血性脑卒中患者短期预后的预测模型[J]. 《中国康复理论与实践》, 2022, 28(3): 335-339.
[5]	朱慧,夏有兵,巩尊科,王世雁,马柯,闫金秋. 高频重复经颅磁刺激对缺血性脑卒中后中枢性面瘫的效果[J]. 《中国康复理论与实践》, 2022, 28(2): 199-203.
[6]	王娜,李培兰,刘芦姗,王丰容. 不同评分系统预测急性缺血性脑卒中患者的短期和长期死亡风险比较[J]. 《中国康复理论与实践》, 2021, 27(3): 256-260.
[7]	王娜娜, 杜小正, 何文洁, 张馨予, 郑欣, 李梦莘. 针刺治疗缺血性脑卒中的Notch信号通路研究进展[J]. 《中国康复理论与实践》, 2021, 27(1): 67-70.
[8]	陈小平,王明洋,马登磊,龚诗立,张丽,李雅莉,李林,胡朝英,张兰. 痘苗病毒致炎兔皮提取物对脑缺血再灌注脑损伤大鼠凋亡和神经炎症的影响[J]. 《中国康复理论与实践》, 2020, 26(9): 1038-1044.
[9]	刘建华,魏清川,胡秀茹,叶赛青,闫志宇,高强. 弥散张量成像各向异性分数与缺血性脑卒中患者上肢运动功能的相关性[J]. 《中国康复理论与实践》, 2020, 26(7): 749-752.
[10]	魏海萍,郭佳,王欢,葛朝明. 迷走神经刺激对脑缺血再灌注大鼠磷酸腺苷活化蛋白激酶-沉默信息调节因子2相关酶1自噬通路的影响[J]. 《中国康复理论与实践》, 2020, 26(7): 775-779.
[11]	刘慧珍,郭树彬,商娜,李芳,刘芦姗,李培兰,陈敬绵,王丰容,李俊玉. 血清25羟基-维生素D对急性缺血性脑卒中急诊患者结局的预测价值[J]. 《中国康复理论与实践》, 2020, 26(7): 830-835.
[12]	龚诗立,杨翠翠,胡朝英,王明洋,张兰. 痘苗病毒致炎兔皮提取物促进小胶质细胞M1向M2极化、抑制炎性因子分泌的体外研究[J]. 《中国康复理论与实践》, 2020, 26(6): 662-667.
[13]	王传杰,吴毅,陶峰,杨雷. 丰富环境对缺血性脑卒中小鼠海马区Bcl-2和Bax蛋白表达和认知功能的效果[J]. 《中国康复理论与实践》, 2020, 26(5): 539-543.
[14]	邓杜萍,范金,谢晓龙,李凌鑫. 调控缺血性脑卒中小胶质细胞极化的药物研究进展[J]. 《中国康复理论与实践》, 2020, 26(5): 559-562.
[15]	符家武,吴昊,李君良,叶烨,陈婧,周海红,李友. microRNA-137基因多态性与缺血性卒中后抑郁的相关性[J]. 《中国康复理论与实践》, 2020, 26(5): 588-591.

血小板活化标志物、维生素D与氯吡格雷抵抗的相关性

Relationship of Platelet Activation Markers and Vitamin D to Clopidogrel Resistance

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0